CIK: 1253074 - Address: 2050, Boul. Rene-Levesque Ouest, Quebec, A8 A1G1R5H6
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/8/07 14:35
4/7/07
PDGIPharmanet Development Group IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA8OSee RemaS-73832.910-22-3248I
3/8/07 18:32
3/7/07
PDGIPharmanet Development Group IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA8OEVP BioaS-12324.060-5-770D
3/7/07 09:55
3/5/07
PDGIPharmanet Development Group IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA8OEVP BioaS-34923.400-15-1676D
5/16/06 20:19
5/12/06
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA8OEVP of LP.m23315.670152090O
9/13/05 18:28
9/9/05
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA1OSVPS-32743.550-8-1351D
3/17/05 16:40
3/15/05
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA1OP of SubS-98838.000-26-3354D
11/15/04 16:33
11/11/04
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA1OP of SubS-26735.600-8-980D
8/3/04 09:42
7/30/04
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA1OP of SubS-25433.920-8-887D
6/28/04 16:23
6/24/04
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA1OP of SubS-21829.060-8-795D
11/6/03 17:25
11/5/03
SFCCSfbc International IncDEHealthBiolabCommercial Physical & BiologiLebel MarcA1OP of SubS-32529.500-11-1468D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact